|
1
|
Kato Y, Ozawa S, Miyamoto C, Maehata Y,
Suzuki A, Maeda T and Baba Y: Acidic extracellular microenvironment
and cancer. Cancer Cell Int. 13:892013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luciani F, Spada M, De Milito A, Molinari
A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone
F, et al: Effect of proton pump inhibitor pretreatment on
resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst.
96:1702–1713. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu ZN, Tian B and Guo X: Repositioning of
proton pump inhibitors in cancer therapy. Cancer Chemother
Pharmacol. 80:925–937. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spugnini EP and Fais S: Drug repurposing
for anticancer therapies. A lesson from proton pump inhibitors.
Expert Opin Ther Pat. 30:15–25. 2020. View Article : Google Scholar
|
|
5
|
Ihraiz WG, Ahram M and Bardaweel SK:
Proton pump inhibitors enhance chemosensitivity, promote apoptosis,
and suppress migration of breast cancer cells. Acta Pharm.
70:179–190. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang B, Ling T, Zhaxi P, Cao Y, Qian L,
Zhao D, Kang W, Zhang W, Wang L, Xu G and Zou X: Proton pump
inhibitor pantoprazole inhibits gastric cancer metastasis via
suppression of telomerase reverse transcriptase gene expression.
Cancer Lett. 452:23–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spugnini EP, Citro G and Fais S: Proton
pump inhibitors as Anti-vacuolar-ATPases drugs: A novel anticancer
strategy. J Exp Clin Cancer Res. 29:442010. View Article : Google Scholar
|
|
8
|
Geeviman K, Babu D and Prakash Babu P:
Pantoprazole induces mitochondrial apoptosis and attenuates NF-κB
signaling in glioma cells. Cell Mol Neurobiol. 38:1491–1504. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He J, Shi XY, Li ZM, Pan XH, Li ZL, Chen
Y, Yan SJ and Xiao L: Proton pump inhibitors can reverse the YAP
mediated paclitaxel resistance in epithelial ovarian cancer. BMC
Mol Cell Biol. 20:492019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu ZN, Shi ZY, Dang YF, Cheng YN, Guan YH,
Hao ZJ, Tian B, He HW and Guo XL: Pantoprazole pretreatment
elevates sensitivity to vincristine in drug-resistant oral
epidermoid carcinoma in vitro and in vivo. Biomed Pharmacother.
120:1094782019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan Q, Wang M, Yu M, Zhang J, Bristow RG,
Hill RP and Tannock IF: Role of autophagy as a survival mechanism
for hypoxic cells in tumors. Neoplasia. 18:347–355. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan Q, Joshua AM, Wang M, Bristow RG,
Wouters BG, Allen CJ and Tannock IF: Up-regulation of autophagy is
a mechanism of resistance to chemotherapy and can be inhibited by
pantoprazole to increase drug sensitivity. Cancer Chemother
Pharmacol. 79:959–969. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan Q, Joshua AM, Saggar JK, Yu M, Wang M,
Kanga N, Zhang JY, Chen X, Wouters BG and Tannock IF: Effect of
pantoprazole to enhance activity of docetaxel against human tumour
xenografts by inhibiting autophagy. Br J Cancer. 112:832–840. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marino ML, Fais S, Djavaheri-Mergny M,
Villa A, Meschini S, Lozupone F, Venturi G, Della Mina P, Pattingre
S, Rivoltini L, et al: Proton pump inhibition induces autophagy as
a survival mechanism following oxidative stress in human melanoma
cells. Cell Death Dis. 1:e872010. View Article : Google Scholar
|
|
15
|
Moriya S, Che XF, Komatsu S, Abe A,
Kawaguchi T, Gotoh A, Inazu M, Tomoda A and Miyazawa K: Macrolide
antibiotics block autophagy flux and sensitize to bortezomib via
endoplasmic reticulum stress-mediated CHOP induction in myeloma
cells. Int J Oncol. 42:1541–1550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Renna M, Schaffner C, Brown K, Shang S,
Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, et
al: Azithromycin blocks autophagy and may predispose cystic
fibrosis patients to mycobacterial infection. J Clin Invest.
121:3554–3563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirasawa K, Moriya S, Miyahara K, Kazama
H, Hirota A, Takemura J, Abe A, Inazu M, Hiramoto M, Tsukahara K
and Miyazawa K: Macrolide antibiotics exhibit cytotoxic effect
under amino Acid-depleted culture condition by blocking autophagy
flux in head and neck squamous cell carcinoma cell lines. PLoS One.
11:e01645292016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mukai S, Moriya S, Hiramoto M, Kazama H,
Kokuba H, Che XF, Yokoyama T, Sakamoto S, Sugawara A, Sunazuka T,
et al: Macrolides sensitize EGFR-TKI-induced non-apoptotic cell
death via blocking autophagy flux in pancreatic cancer cell lines.
Int J Oncol. 48:45–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sugita S, Ito K, Yamashiro Y, Moriya S,
Che XF, Yokoyama T, Hiramoto M and Miyazawa K: EGFR-independent
autophagy induction with gefitinib and enhancement of its cytotoxic
effect by targeting autophagy with clarithromycin in non-small cell
lung cancer cells. Biochem Biophys Res Commun. 461:28–34. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Komatsu S, Miyazawa K, Moriya S, Takase A,
Naito M, Inazu M, Kohno N, Itoh M and Tomoda A: Clarithromycin
enhances Bortezomib-induced cytotoxicity via endoplasmic reticulum
Stress-mediated CHOP (GADD153) induction and autophagy in breast
cancer cells. Int J Oncol. 40:1029–1039. 2012. View Article : Google Scholar
|
|
21
|
Yang JC, Lu CW and Lin CJ: Treatment of
Helicobacter pylori infection: Current status and future concepts.
World J Gastroenterol. 20:5283–5293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saito Y, Moriya S, Kazama H, Hirasawa K,
Miyahara K, Kokuba H, Hino H, Kikuchi H, Takano N, Hiramoto M, et
al: Amino acid starvation culture condition sensitizes
EGFR-expressing cancer cell lines to gefitinib-mediated
cytotoxicity by inducing atypical necroptosis. Int J Oncol.
52:1165–1177. 2018.PubMed/NCBI
|
|
23
|
O'Prey J, Sakamaki J, Baudot AD, New M,
Van Acker T, Tooze SA, Long JS and Ryan KM: Application of
CRISPR/Cas9 to autophagy research. Methods Enzymol. 588:79–108.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ran FA, Hsu PD, Wright J, Agarwala V,
Scott DA and Zhang F: Genome engineering using the CRISPR-Cas9
system. Nat Protoc. 11:2281–2308. 2013. View Article : Google Scholar
|
|
25
|
Aits S, Kricker J, Liu B, Ellegaard AM,
Hämälistö S, Tvingsholm S, Corcelle-Termeau E, Høgh S, Farkas T,
Holm Jonassen A, et al: Sensitive detection of lysosomal membrane
permeabilization by lysosomal galectin puncta assay. Autophagy.
11:1408–1424. 2015. View Article : Google Scholar :
|
|
26
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the nomenclature committee on cell death 2018. Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mizushima N and Yoshimori T: How to
interpret LC3 immunoblotting. Autophagy. 3:542–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang F, Gómez-Sintes R and Boya P:
Lysosomal membrane permeabilization and cell death. Traffic.
19:918–931. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aits S and Jäättelä M: Lysosomal cell
death at a glance. J Cell Sci. 126:1905–1912. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andrea B and Juan SB: Lysosomes as dynamic
regulators of cell and organismal homeostasis. Nat Rev Mol Cell
Biol. 21:101–118. 2020. View Article : Google Scholar
|
|
31
|
Zhang S, Wang Y and Li SJ: Lansoprazole
induces apoptosis of breast cancer cells through inhibition of
intracellular proton extrusion. Biochem Biophys Res Commun.
448:424–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu W, Baker SS, Trinidad J, Burlingame
AL, Baker RD, Forte JG, Virtuoso LP, Egilmez NK and Zhu L:
Inhibition of lysosomal enzyme activities by proton pump
inhibitors. J Gastroenterol. 48:1343–1352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Česen MH, Pegan K, Spes A and Turk B:
Lysosomal pathways to cell death and their therapeutic
applications. Exp Cell Res. 318:1245–1251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhitomirsky B, Yunaev A, Kreiserman R,
Kaplan A, Stark M and Assaraf YG: Lysosomotropic drugs activate
TFEB via lysosomal membrane fluidization and consequent inhibition
of mTORC1 activity. Cell Death Dis. 9:11912018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ballabio A and Bonifacino JS: Lysosomes as
dynamic regulators of cell and organismal homeostasis. Nat Rev Mol
Cell Biol. 21:101–118. 2020. View Article : Google Scholar
|
|
36
|
Papadopoulos C, Kravic B and Meyer H:
Repair or lysophagy: Dealing with damaged lysosomes. J Mol Biol.
432:231–239. 2020. View Article : Google Scholar
|
